MicroRNA Correlates of Childhood Maltreatment and Suicidality

Sponsor
University of Alabama at Birmingham (Other)
Overall Status
Recruiting
CT.gov ID
NCT04923685
Collaborator
National Institute of Mental Health (NIMH) (NIH)
450
2
54.1
225
4.2

Study Details

Study Description

Brief Summary

This is a research study to find out if childhood trauma and stress are associated with depression or suicidal risk. The study will assess the effects of both short-term and long-term stress on biomarker (e.g. miRNA [MiRNA]) levels. miRNAs are a type of RNA (genetic material that is translated into protein) that are found in throughout the body and blood. They are called microRNA because their size is much smaller than typical RNA molecules. miRNAs are highly responsive to environment. This responsiveness is reflected in their expression in individuals who are affected by environment such as stress. The investigators are gathering genetic material, including DNA and RNA, from each participant. The RNA will be taken from the small vesicles and cells in the participant's blood and analyzed. The vesicles are small objects that occur normally in the blood and that contain RNA. This information may help us to understand the cause of mental illness and to improve medical and psychiatric care in the future. There will be 450 participants enrolled in this study.

Condition or Disease Intervention/Treatment Phase
  • Other: Trier Social Stress Test

Detailed Description

The purpose of the study is to determine if the relationship between a history of childhood maltreatment (CM) and suicide risk is associated with alterations in the expression and epigenetic modification of specific microRNAs (miRNAs), thereby providing a molecular signature of suicide risk in people with CM. miRNAs are short regulatory RNAs that transduce environmental events into changes in protein synthesis in cells. The environment can induce permanent changes in miRNA expression. Aim 1 is to identify a set of neural-derived exosomal miRNAs that are associated with the interaction of suicidality and CM. Aim 2 is to examine whether an acute experimental stressor, the Trier Social Stress Test (TSST), impacts the expression of these miRNAs in suicidal patients with and without CM. Aim 3 will examine potential mechanisms by which altered miRNAs may contribute to CM-associated suicidal behavior. Aim 4 will examine if changes in CM-associated miRNAs are explained by modifications in their DNA methylation.

Study Design

Study Type:
Observational
Anticipated Enrollment :
450 participants
Observational Model:
Cohort
Time Perspective:
Other
Official Title:
MicroRNA Correlates of Childhood Maltreatment and Suicidality
Actual Study Start Date :
Feb 26, 2021
Anticipated Primary Completion Date :
Sep 1, 2025
Anticipated Study Completion Date :
Sep 1, 2025

Arms and Interventions

Arm Intervention/Treatment
MDD with elevated CM and suicidality scores

Major Depressive Disorder with elevator childhood maltreatment and suicidality scores.

Other: Trier Social Stress Test
The TSST is a standardized test to induce acute psychological stress in humans. Participants will abstain from caffeine for 12 hours and nicotine for 2 hours prior to the test. An IV butterfly catheter will be placed in an arm vein and flushed with saline. Participants will rest for 15 minutes. A 10ml baseline blood sample will be drawn. They will perform the TSST task and then have 10ml of blood drawn at 0, 15, 30, 60, and 90 minutes post-TSST.
Other Names:
  • TSST
  • MDD with CM history but lower suicidality

    Major Depressive disorder with childhood maltreatment history but lower suicidality scores.

    Other: Trier Social Stress Test
    The TSST is a standardized test to induce acute psychological stress in humans. Participants will abstain from caffeine for 12 hours and nicotine for 2 hours prior to the test. An IV butterfly catheter will be placed in an arm vein and flushed with saline. Participants will rest for 15 minutes. A 10ml baseline blood sample will be drawn. They will perform the TSST task and then have 10ml of blood drawn at 0, 15, 30, 60, and 90 minutes post-TSST.
    Other Names:
  • TSST
  • MDD without CM but with elevated suicidality

    Major Depressive Disorder without childhood maltreatment, but with elevated suicidality scores.

    Other: Trier Social Stress Test
    The TSST is a standardized test to induce acute psychological stress in humans. Participants will abstain from caffeine for 12 hours and nicotine for 2 hours prior to the test. An IV butterfly catheter will be placed in an arm vein and flushed with saline. Participants will rest for 15 minutes. A 10ml baseline blood sample will be drawn. They will perform the TSST task and then have 10ml of blood drawn at 0, 15, 30, 60, and 90 minutes post-TSST.
    Other Names:
  • TSST
  • MDD without CM but with lower suicidality

    Major Depressive Disorder without childhood maltreatment but with lower suicidality scores.

    Other: Trier Social Stress Test
    The TSST is a standardized test to induce acute psychological stress in humans. Participants will abstain from caffeine for 12 hours and nicotine for 2 hours prior to the test. An IV butterfly catheter will be placed in an arm vein and flushed with saline. Participants will rest for 15 minutes. A 10ml baseline blood sample will be drawn. They will perform the TSST task and then have 10ml of blood drawn at 0, 15, 30, 60, and 90 minutes post-TSST.
    Other Names:
  • TSST
  • Healthy controls with CM history

    Healthy controls with childhood maltreatment history,

    Other: Trier Social Stress Test
    The TSST is a standardized test to induce acute psychological stress in humans. Participants will abstain from caffeine for 12 hours and nicotine for 2 hours prior to the test. An IV butterfly catheter will be placed in an arm vein and flushed with saline. Participants will rest for 15 minutes. A 10ml baseline blood sample will be drawn. They will perform the TSST task and then have 10ml of blood drawn at 0, 15, 30, 60, and 90 minutes post-TSST.
    Other Names:
  • TSST
  • Healthy controls without CM history

    Healthy controls without childhood maltreatment history.

    Other: Trier Social Stress Test
    The TSST is a standardized test to induce acute psychological stress in humans. Participants will abstain from caffeine for 12 hours and nicotine for 2 hours prior to the test. An IV butterfly catheter will be placed in an arm vein and flushed with saline. Participants will rest for 15 minutes. A 10ml baseline blood sample will be drawn. They will perform the TSST task and then have 10ml of blood drawn at 0, 15, 30, 60, and 90 minutes post-TSST.
    Other Names:
  • TSST
  • Outcome Measures

    Primary Outcome Measures

    1. MicroRNA response to stress [24 hours]

      MiRNAs methylation levels will be examined

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 60 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    1. Age 18-60

    2. Physically healthy

    3. Willing and able to provide informed consent

    4. Diagnosis of MDD or No history of mental illness

    Exclusion Criteria:
    1. Pregnancy or lactation (women of reproductive potential must have a negative urine pregnancy screen)

    2. Post-partum state (being within 2 months of delivery or miscarriage)

    3. Homicide risk as determined by clinical interview

    4. A lifetime history of psychotic disorder

    5. Any history of dissociation or dissociative disorder

    6. Bipolar disorder

    7. Pervasive developmental disorder

    8. Cognitive disorder

    9. Cluster A personality disorder

    10. Borderline personality disorder

    11. Anorexia nervosa

    12. Alcohol or drug dependence (except nicotine and caffeine) within the last month or the use of any hallucinogen (except cannabis), including phencyclidine in the last month (NOTE that a positive UDS is not exclusionary except for hallucinogens, methamphetamine, or cocaine. People presenting intoxicated with alcohol may be included when a Breathalyzer test (Alco-Sensor IV) is negative as long as there is no history of recent dependence.

    13. Recent myocardial infarction

    14. Unstable angina

    15. Active neoplasm in the past 6 months

    16. Immunosuppressive or corticosteroid therapy within the last month, with the following exceptions: any inhaled, intranasal, topical or vaginal corticosteroids are allowed.

    17. Chemotherapy

    18. Head injury with loss of consciousness in the past 6 months

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 University of Alabama at Birmingham Birmingham Alabama United States 35233
    2 UAB Huntsville Regional Medical Campus Huntsville Alabama United States 35294

    Sponsors and Collaborators

    • University of Alabama at Birmingham
    • National Institute of Mental Health (NIMH)

    Investigators

    • Principal Investigator: Yogesh Dwivedi, PhD, University of Alabama at Birmingham

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Yogesh Dwivedi, PhD, Professor, University of Alabama at Birmingham
    ClinicalTrials.gov Identifier:
    NCT04923685
    Other Study ID Numbers:
    • IRB-300006024
    First Posted:
    Jun 11, 2021
    Last Update Posted:
    Apr 13, 2022
    Last Verified:
    Apr 1, 2022
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Yogesh Dwivedi, PhD, Professor, University of Alabama at Birmingham
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Apr 13, 2022